Effects of a novel guanylate cyclase inhibitor on nitric oxide‐dependent inhibitory neurotransmission in canine proximal colon
Open Access
- 1 November 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (6) , 1223-1229
- https://doi.org/10.1038/sj.bjp.0701487
Abstract
1. Previous studies suggested that nitric oxide (NO) may cause hyperpolarization and relaxation of canine colonic smooth muscle by both cGMP-dependent and cGMP-independent mechanisms. This hypothesis was tested using 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one (ODQ), a novel inhibitor of NO-stimulated guanylate cyclase. 2. In the presence of histamine (30 microM), atropine and indomethacin (both at 1 microM), electrical field stimulation of intrinsic neurons (EFS; 5 Hz) produced inhibition of phasic contractile activity that is due to NO synthesis. ODQ caused a concentration-dependent block of this response (10 nM to 10 microM). 3. Inhibitory junction potentials (IJPs) due to NO synthesis were recorded from muscle cells located near the myenteric border of the circular muscle layer, using intracellular microelectrodes. IJPs were abolished by ODQ (1-10 microM). 4. EFS (10-20 Hz) produced frequency-dependent inhibition of electrical slow waves recorded from cells located near the submucosal surface of the circular muscle layer. This inhibition is due to NO synthesis, and it was abolished by ODQ (1-10 microM). 5. Hyperpolarization and relaxation produced by an NO donor, sodium nitroprusside, were abolished by ODQ pretreatment (1-10 microM). In contrast, inhibitory responses to 8-Br-cGMP (1 mM) were unaffected by ODQ. 6. ODQ alone (1-10 microM) had no significant effect on spontaneous electrical or phasic contractile activity. In tissues pre-treated with L-NAME (300 microM), ODQ decreased the amplitude of spontaneous or histamine-stimulated phasic contractile activity. 7. These results suggest that electrical and mechanical effects of endogenously released and exogenously applied NO in canine colon are largely due to cGMP synthesis by ODQ-sensitive soluble guanylate cyclase. No evidence to support a direct (cGMP-independent) mechanism of NO action was found. ODQ also appears to cause a non-specific inhibition of muscle contractile activity; however, this effect does not contribute to block of NO-dependent effects.Keywords
This publication has 36 references indexed in Scilit:
- Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclaseBritish Journal of Pharmacology, 1996
- Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin‐1 secretionFEBS Letters, 1995
- Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclaseNeuroscience, 1995
- Nitric Oxide Signaling in the Central Nervous SystemAnnual Review of Physiology, 1995
- Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscleNature, 1994
- Involvement of cAMP and cGMP in relaxation of internal anal sphincter by neural stimulation, VIP, and NOAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1993
- Effect of LY 83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundusEuropean Journal of Pharmacology, 1992
- Guanylate cyclase inhibitors: effect on inhibitory junction potentials in esophageal smooth muscleAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1992
- Nitric oxide, a novel neuronal messengerNeuron, 1992
- Involvement of nitric oxide synthetic pathway in inhibitory junction potentials in canine proximal colonAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1991